Marathon Capital Management Gsk PLC Transaction History

Marathon Capital Management

$399 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $104,494 - $118,708	-2,485 Reduced 2.37%	102,241 $4.45 Million
Q1 2022 May 13, 2022	SELL	$40.23 - $47.74 $16,856 - $20,003	-419 Reduced 0.4%	104,726 $4.56 Million
Q4 2021 Feb 09, 2022	SELL	$38.88 - $45.31 $29,393 - $34,254	-756 Reduced 0.71%	105,145 $4.64 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $4,383 - $4,877	113 Added 0.11%	105,901 $4.05 Million
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $11,467 - $13,018	-314 Reduced 0.3%	105,788 $4.21 Million
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $177,621 - $207,371	5,183 Added 5.14%	106,102 $3.79 Million
Q4 2020 Feb 08, 2021	SELL	$34.07 - $39.94 $425,568 - $498,890	-12,491 Reduced 11.01%	100,919 $3.71 Million
Q3 2020 Nov 16, 2020	SELL	$38.11 - $42.99 $163,034 - $183,911	-4,278 Reduced 3.64%	113,410 $4.27 Million
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $1.6 Million - $1.84 Million	42,300 Added 56.11%	117,688 $4.8 Million
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $7,922 - $11,914	-244 Reduced 0.32%	75,388 $2.86 Million
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $194,628 - $223,590	4,634 Added 6.53%	75,632 $3.55 Million
Q3 2019 Nov 13, 2019	BUY	$40.46 - $43.52 $4,288 - $4,613	106 Added 0.15%	70,998 $3.03 Million
Q2 2019 Jul 25, 2019	SELL	$39.4 - $42.7 $25,807 - $27,968	-655 Reduced 0.92%	70,892 $2.84 Million
Q1 2019 May 15, 2019	SELL	$38.57 - $42.69 $40,267 - $44,568	-1,044 Reduced 1.44%	71,547 $2.99 Million
Q4 2018 Feb 07, 2019	SELL	$37.8 - $42.69 $220,184 - $248,669	-5,825 Reduced 7.43%	72,591 $2.77 Million
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $50,283 - $54,002	-1,265 Reduced 1.59%	78,416 $3.15 Million
Q2 2018 Aug 07, 2018	BUY	$39.61 - $42.76 $13,348 - $14,410	337 Added 0.42%	79,681 $3.21 Million
Q1 2018 May 07, 2018	BUY	$36.18 - $40.15 $373,015 - $413,946	10,310 Added 14.93%	79,344 $3.1 Million
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $12,404 - $14,706	-351 Reduced 0.51%	69,034 $2.45 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $2.74 Million - $2.88 Million	69,385	69,385 $2.82 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Capital Management with notifications on news.

Account